TAO Synergies Inc
synaptogen.comWhat Do They Do?
Uses excess cash to buy and stake TAO, seeking staking rewards from the Bittensor network.
10-K for FY2025, filed Mar 31, 2026
How Are They Changing?
From drug development to a TAO treasury strategy
The older report describes developing a drug candidate for Alzheimer’s disease and other conditions. The latest report describes putting excess cash into TAO and staking it for rewards.
10-K for FY2022, filed Mar 21, 2023 10-K for FY2025, filed Mar 31, 2026We are a biopharmaceutical company with product candidates in pre-clinical and clinical development. We are principally focused on…View ↗
Loading...
